Variant report
Variant | esv3433117 |
---|---|
Chromosome Location | chr12:86367321-86373219 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs532002497 | chr12:86369042-86369043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs546988238 | chr12:86369049-86369050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs141778537 | chr12:86369092-86369093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs550399468 | chr12:86369113-86369114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10506913 | chr12:86369119-86369120 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs182157661 | chr12:86369213-86369214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs78208243 | chr12:86369217-86369218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569047356 | chr12:86369302-86369303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs539539344 | chr12:86369331-86369332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs558182269 | chr12:86369344-86369345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs566555966 | chr12:86369379-86369380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111306281 | chr12:86369383-86369384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533952407 | chr12:86369419-86369420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs555394846 | chr12:86369421-86369422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534521566 | chr12:86369424-86369425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs573960655 | chr12:86369445-86369446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs548008810 | chr12:86369446-86369447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs143763063 | chr12:86369450-86369451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs148178651 | chr12:86369476-86369477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs202150805 | chr12:86369509-86369510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577859851 | chr12:86369547-86369548 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544780289 | chr12:86369552-86369553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs370906083 | chr12:86369554-86369555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576148256 | chr12:86369601-86369602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs528696158 | chr12:86369604-86369605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190400488 | chr12:86369634-86369635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs537275904 | chr12:86369670-86369671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34251866 | chr12:86369688-86369689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533569305 | chr12:86369705-86369706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs562073987 | chr12:86369728-86369729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs721829 | chr12:86369784-86369785 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs550604119 | chr12:86369847-86369848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs568912897 | chr12:86369897-86369898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs533315327 | chr12:86369930-86369931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs551597909 | chr12:86369946-86369947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs566926836 | chr12:86369947-86369948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs10863129 | chr12:86369952-86369953 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs537796437 | chr12:86369963-86369964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs549143738 | chr12:86369986-86369987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567606122 | chr12:86370069-86370070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs543182248 | chr12:86370087-86370088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542142385 | chr12:86370179-86370180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs556450915 | chr12:86370193-86370194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs577722283 | chr12:86370195-86370196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs538596385 | chr12:86370255-86370256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs556032382 | chr12:86370368-86370369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142014376 | chr12:86370383-86370384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572087484 | chr12:86370389-86370390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73176276 | chr12:86370403-86370404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs553993027 | chr12:86370407-86370408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 22032731 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:86369000-86371000 | Enhancers | HUVEC | blood vessel |
2 | chr12:86372800-86375800 | Weak transcription | Fetal Heart | heart |